Abstract-A peptide nucleic acid (PNA)-cell-penetrating peptide (CPP) conjugate (carrier PNA) was used as "bridge-builder" to connect a CPP with an shRNA. The carrier PNA successfully formed a hybrid with an shRNA bearing complementary dangling bases and the shRNA was introduced into cells by the carrier PNA, and RNAi was induced by the shRNA.
Short double-stranded RNAs, termed small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs), decompose a target mRNA sequence-specifically on the basis of RNA interference (RNAi) and downregulate the specific gene expression in cells.
1 RNAi is commonly used as a tool to analyze a genetic function in biochemical and medical fields. These RNAs are attractive therapeutic candidates for interferring with the expression of undesirable genes. Since siRNA and shRNA cannot introduce themselves into cells, various delivery systems for carrying these RNAs have been developed. 3 Of these delivery systems, some delivery system using cell-penetrating peptides (CPPs) as the carriers for RNAs have been reported 4 and several studies have shown that siRNAs connected with CPPs (siRNA-CPPs) entered cells. 5 The advantage of this method is that an excess amount of RNA carrier reagents is not necessary due to the direct connection between the siRNAs and the CPP. However, this method needs time-consuming synthesis of the siRNA-CPP for every siRNA. A simpler way to connect the CPP and every RNA is needed. In this report, we describe a new method to connect an siRNA or shRNA with a CPP more simply and rapidly. To achieve this purpose, we utilized a peptide nucleic acid (PNA). 6 The PNA is a peptide-based nucleic acid surrogate consisting of nucleobases in the side chain, and the PNA can form a more stable hybrid with a complementary nucleic acid than nucleic acids themselves because of the absence of electrostatic repulsion between PNAs and nucleic acids. First, we synthesized a PNA conjugated to a CPP (carrier PNA). Synthesis of a PNA conjugated to a CPP was much easier than synthesis of an siRNA-CPP because both the PNA and the CPP can be connected by amide bonds from solid-phase peptide synthesis (SPPS). Next, we synthesized an shRNA bearing complementary dangling bases to the PNA moiety in the carrier PNA. When the carrier PNA is mixed with the shRNA, the shRNA easily connects to the CPP, resulting in the formation of a hybrid between the dangling bases and the PNA moiety. This method also has the advantage that the carrier PNA can be utilized as a carrier of any shRNA and siRNA bearing complementary dangling bases. In general, a PNA conjugated to a CPP is used as an antisense agent, 7 whereas we used the carrier PNA as a "bridge-builder" to connect a CPP with an shRNA in this work. Fig. S1 ). The chemical structure of the carrier PNA is shown in Fig. 1 . The sequence of PNA is N'-TGGTGCGAA-C' and the CPP is octaarginine (R8). An R8 efficiently translocates through the cell membranes and works as a carrier. 8 Fig. 1 . The anti-Luc shRNA was obtained by transcription using T7 RNA polymerase.
9
Dangling bases of the 5' end in the anti-Luc shRNA are complementary with the PNA moiety in the carrier PNA. We preliminary investigated whether the carrier PNA formed hybrids with nucleic acids. The UV melting curve of an equimolar mixture of the carrier PNA and a complementary DNA is shown in Fig 2. 10 In the case of detection at 260 nm derived from nucleobases, it was shown that the carrier PNA formed a hybrid with a complementary DNA. The melting temperature (T m ) was 70.6 ˚C. A UV melting curve of an equimolar mixture of carrier PNA without an R8 (H-PNA(TGGTGCGAA)-NH 2 ) and the complementary DNA was also measured. The T m value was 68.6 ˚C. These results indicate that the conjugation of a cationic R8 to a PNA does not noticeably affect hybridization of the PNA with a complementary DNA. A similar result was also reported in a paper on duplex stability of DNAs conjugated to a cationic oligomer and a complementary DNA.
11 Although a UV melting curve for an equimolar mixture of the carrier PNA and a mismatched DNA was like a sigmoid curve (detection at 260 nm), absorbance at 350 nm increased at low temperatures, suggesting that aggregation of the carrier PNAs and the mismatched DNAs was promoted due to electrostatic interactions between CPPs and DNAs instead of the formation of a hybrid. Such a rise of turbidity was not observed between the carrier PNA and the complementary DNA. These results suggest that hybridization between the PNA moiety in the carrier PNA and the complementary DNA preferentially proceeded compared to the nonspecific interaction between cationic CPPs and anionic DNAs. These results also suggest that the carrier PNA will sequencespecifically transport nucleic acids into cells. Cellular internalization of the hybrid between the carrier PNA and a longer DNA was examined by confocal laser-scanning microscopy.
12 A fluorescence image of Chinese hamster ovary (CHO) cells obtain after equilibration with hybrids of the carrier PNA with an FAM-labeled DNA bearing complementary bases to the PNA moiety is shown in Fig. 3a . The intracellular location of the hybrid was mostly confined in small vesicular compartments. This result indicates that the hybrid is successfully introduced into the cells by the endosomal pathway. On the other hand, the FAMlabeled DNA was not internalized with an R8 by the cells under same conditions (Fig. 3b) . In addition, the FAM-labeled DNA alone was not internalized by the cells. These results suggest that the PNA moiety has an important role in the introduction of specific nucleic acids into cells. In other words, these results indicate that the nucleic acids were introduced through the carrier PNA into cells when the PNA moiety formed a hybrid with the nucleic acid. We investigated the RNAi effect of an shRNA with the carrier PNA in cells. 13 The carrier PNA and then an anti-Luc shRNA were added to the medium supplemented with fetal bovine serum (FBS) on CHO cells expressing firefly luciferase (CHO-AA8-Luc cells), and the cells were incubated. The final concentrations of a mixture of the carrier PNA and the anti-Luc shRNA were 250 nM and 500 nM, respectively. Fig. 4a shows luciferase expression in the cells. As negative control experiments, we also measured luciferase activities of cells incubated with the anti-Luc shRNA alone and cells incubated with a mixture of the anti-Luc shRNA and a carrier PNA containing a mismatched PNA sequence (carrier misPNA). Compared to the result of the negative control experiments, the anti-Luc shRNA with the carrier PNA suppressed luciferase expression to 22% in the case of 250 nM of the hybrid and to 38% in the case of 500 nM of the hybrid.
14 Fig. 4b shows that the RNAi effect was observed 18-24 h after incubation with the carrier PNA/shRNA hybrid. These results suggest that the carrier PNA introduced the shRNA into cells. The mixture of the carrier misPNA and the antiLuc shRNA did not suppress luciferase expression, indicating that the shRNA was successfully introduced into cells by the carrier PNA via formation of a sequence-specific PNA/RNA hybrid. In summary, we have developed the new method to introduce an shRNA (or siRNA) into cells. The carrier PNA successfully formed a hybrid with an shRNA bearing complementary dangling bases and the shRNA was introduced into cells by the carrier PNA, and then RNAi was induced by the shRNA. When shRNAs and siRNAs bearing complementary dangling bases are prepared, any kinds of RNAs will be introduced by the carrier PNA into cells. Escape of the carrier PNA/shRNA hybrid from the endosome is currently under investigation.
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